Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction

This publication has 28 references indexed in Scilit:

• Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells
  International Journal of Cancer, 1998
• Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells
  Biochemical Pharmacology, 1998
• Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions.
  Gastroenterology, 1997
• Sulindac sulfide induces several subpopulations of colon cancer cells, defined by PCNA/Ki-67 and DNA strand breaks
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
• Sulindac sulfide inhibits the proliferation of colon cancer cells: diminished expression of the proliferation markers PCNA and Ki-67
  Cancer Letters, 1997
• Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
  Journal of Biological Chemistry, 1996
• Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis
  Experimental Cell Research, 1996
• The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis
  Gastroenterology, 1995
• Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
  Journal of Clinical Investigation, 1995
• The mechanisms of action of nonsteroidal antiinflammatory drugs
  Arthritis & Rheumatism, 1989